1135596

Corcept Therapeutics Incorporated — FEI 3005389393

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 19, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Redwood City, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)